Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Finance Watch: Q1 Biopharma Venture Capital Dips From All-Time High, But Numbers Still Impress

Apr 09 2019

• By Mandy Jackson

Finance Watch

Related Content

Finance Watch: Arteaus Comes Full Circle As Investors Monetize Emgality Royalties

Apr 01 2019

Venture Funding Deals: New Cash For Delinia, Peloton, Fortis & Others

Oct 13 2016

Finance Watch: 5AM, Longevity Close Funds, New Incubators Launch To Support Early-Stage Companies

Feb 18 2019

Finance Watch: Scripps Research Models A New Way To Fund Translation

Feb 26 2019

Finance Watch: Genocea, Mateon Shift Strategies, Cut Jobs To Preserve Cash

Sep 28 2017

Finance Watch: VC Investment Soars In Q1, Putting Biopharma On Track For A Record Year

Apr 15 2018

Finance Watch: Former Juno Execs Launch Sana With Allogeneic Cell Therapy Platform

Jan 07 2019

Finance Watch: VC Mega-Deals Launch Biopharma Firms With New Takes On CV, Genetic Diseases

Mar 05 2019

Related Companies

Anthos Therapeutics Inc.

Maze Therapeutics, Inc.

Passage Bio

Sio Gene Therapies, Inc.

Arvelle Therapeutics GmbH

Antengene Corporation

Fusion Pharmaceuticals Inc.

Pfizer Inc.

SpringWorks Therapeutics Inc.

Dyne Therapeutics

Aura Biosciences, Inc.

argenx N.V.

Angion Biomedica Corp.

Additional Topics

Financing StartUps and SMEs Growth Deals Innovation Commercial BioPharmaceutical

More from Financing

More from Business

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window